AI assistant
Twist Bioscience Corp — Director's Dealing 2021
Apr 23, 2021
31873_dirs_2021-04-23_810d25ee-516c-40d6-9077-6477377ae69f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-04-21
Reporting Person: Weiss Patrick (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-21 | Common Stock | M | 2105 | $8.82 | Acquired | 54589 | Direct |
| 2021-04-21 | Common Stock | M | 1974 | $26.66 | Acquired | 56563 | Direct |
| 2021-04-21 | Common Stock | M | 827 | $25.02 | Acquired | 57390 | Direct |
| 2021-04-21 | Common Stock | S | 4906 | $124.42 | Disposed | 52484 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-21 | Employee Stock Option (right to buy) | $8.82 | M | 2105 | Disposed | 2027-09-28 | Common Stock (2105) | Direct |
| 2021-04-21 | Employee Stock Option (right to buy) | $26.66 | M | 1974 | Disposed | 2028-11-18 | Common Stock (1974) | Direct |
| 2021-04-21 | Employee Stock Option (right to buy) | $25.02 | M | 827 | Disposed | 2029-12-09 | Common Stock (827) | Direct |
Footnotes
F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020.
F2: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F3: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F4: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.